This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration:
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
PSI Members
£495
Non-Members
£590
After 23rd March
PSI Members
£595
Non-Members
£690
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration:
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
PSI Members
£495
Non-Members
£590
After 23rd March
PSI Members
£595
Non-Members
£690
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration:
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
PSI Members
£495
Non-Members
£590
After 23rd March
PSI Members
£595
Non-Members
£690
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration:
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
PSI Members
£495
Non-Members
£590
After 23rd March
PSI Members
£595
Non-Members
£690
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration:
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
PSI Members
£495
Non-Members
£590
After 23rd March
PSI Members
£595
Non-Members
£690
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.
This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration:
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
PSI Members
£495
Non-Members
£590
After 23rd March
PSI Members
£595
Non-Members
£690
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact psi@mci-group.com to make a reservation.
Upcoming Events
PSI Training Course: Effective Leadership – the keys to growing your leadership capabilities
This course will consist of three online half-day workshops. The first will be aimed at building trust, the backbone of leadership and a key to becoming effective. This is key to building a solid foundation.
The second will be on improving communication as a technical leader. This workshop will focus on communication strategies for different stakeholders and will involve tips on effective communication and how to develop the skills of active listening, coaching and what improv can teach us about good communication.
The final workshop will bring these two components together to help leaders become more influential. This will also focus on how to use Steven Covey’s 7-Habits, in particular Habits 4, 5 and 6, which are called the habits of communication.
The workshops will be interactive, allowing you to practice the concepts discussed. There will be plenty of time for questions and discussion. There will also be reflective time where you can think about what you are learning and how you might experiment with it.
PSI Introduction to Industry Training (ITIT) Course - 2026/2027
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.
Statisticians in the Age of AI: On Route to Strategic Partnership
A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
GSK - Statistics Director - Vaccines and Infectious Disease
We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.
As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.
: We have an exciting opportunity for an Associate Director (AD), Statistical Programming, to join a passionate team within Advanced Quantitative Sciences- Development.
Novartis - Senior Principal Statistical Programmer
We have an exciting opportunity for a Senior Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.
Pierre Fabre - Clinical Development Safety Statistics Expert M/F
We are seeking a highly skilled and proactive Clinical Development Safety Statistics Expert to join our Biometry Department and the Biometry Leadership Team based in Toulouse (31, Oncopole) or Boulogne (92).
Pierre Fabre - Lead Statistician – Real World Evidence -CDI- M/F
Pierre Fabre Laboratories are hiring a highly skilled and experienced Lead Statistician – Real World Evidence (RWE) to join the Biometry Department, part of the Data Science & Biometry Department, based in Toulouse (Oncopôle) or Boulogne.
Pierre Fabre - Lead Statistician- Clinical Trials M/F
We are seeking a highly skilled and experienced Lead Statistician in Clinical Trials to join our Biometry Department based in Toulouse (31, Oncopole) or Boulogne (92).
We are looking for Senior Statistical Programmers in the UK to join Veramed, where you'll deliver high-impact programming solutions in an FSP-style capacity, while advancing your career in a supportive, growth-driven environment.
